… Alzheimer's disease (AD). Atrophy of brain tissue was a common finding, but a critical review
in 1990 concluded that “at present there is little definite evidence for clear anatomic brain …

… The progression of tau pathology is stepwise and stereotyped from the entorhinal cortex, …
Various clinico-pathological types of Alzheimer disease have been described, according to the …

… versus those that occur in the setting of Alzheimer's disease (AD). Since putative biomarkers
… disease, is the pathological progression consistent with a linear amyloid-tau progression. …

… in Alzheimer disease (AD). The presumptions inherent in most studies and in the dogma of
the amyloid cascade concept are that these hallmark lesions in AD brains contain molecules …

… for the identification of blood-based Alzheimer disease (AD) biomarkers associated with
both in vivo disease pathology as well as rate of disease progression. C, Association of plasma …

… disease (AD) and cerebrovascular lesions that may magnify the effect of mild AD pathology
and promote progression of … Vascular pathology in the aging brain and in AD includes: 1. …

… AD pathology and disease progression (Endophenotype Association Score in Early Alzheimer’s
Disease [… severity of AD pathology at autopsy and AD progression across prodromal and …

… not affect AD-specific pathologic progression, suggesting that the … Alzheimer disease (AD)
and vascular pathology are common in the elderly population, and multiple brain pathologic …

… marker for diagnostic purposes and as a measurement of clinical progression of AD. Alzheimer
disease pathological markers develop in vulnerable brain regions in an uneven manner …

… in both physiological and pathological settings. Here, we analysed the impact of regulatory
T cells on spontaneous disease progression in a murine model of Alzheimer’s disease. Early …